- Home
- NYXH vs SXTC Comparison
NYXH vs SXTC Comparison
Compare NYXH & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYXH
- SXTC
- Stock Information
- Founded
- NYXH 2009
- SXTC 2005
- Country
- NYXH Belgium
- SXTC China
- Employees
- NYXH N/A
- SXTC N/A
- Industry
- NYXH Medical/Dental Instruments
- SXTC Biotechnology: Pharmaceutical Preparations
- Sector
- NYXH Health Care
- SXTC Health Care
- Exchange
- NYXH Nasdaq
- SXTC Nasdaq
- Market Cap
- NYXH 179.1M
- SXTC 164.8M
- IPO Year
- NYXH 2021
- SXTC 2019
- Fundamental
- Price
- NYXH $4.78
- SXTC $1.90
- Analyst Decision
- NYXH Strong Buy
- SXTC
- Analyst Count
- NYXH 3
- SXTC 0
- Target Price
- NYXH $15.00
- SXTC N/A
- AVG Volume (30 Days)
- NYXH 60.4K
- SXTC 860.1K
- Earning Date
- NYXH 11-05-2025
- SXTC 01-01-0001
- Dividend Yield
- NYXH N/A
- SXTC N/A
- EPS Growth
- NYXH N/A
- SXTC N/A
- EPS
- NYXH N/A
- SXTC N/A
- Revenue
- NYXH $5,793,306.00
- SXTC $1,740,907.00
- Revenue This Year
- NYXH $118.20
- SXTC N/A
- Revenue Next Year
- NYXH $278.04
- SXTC N/A
- P/E Ratio
- NYXH N/A
- SXTC N/A
- Revenue Growth
- NYXH 2.94
- SXTC N/A
- 52 Week Low
- NYXH $4.56
- SXTC $0.95
- 52 Week High
- NYXH $11.87
- SXTC $7.84
- Technical
- Relative Strength Index (RSI)
- NYXH 26.11
- SXTC 60.38
- Support Level
- NYXH $4.56
- SXTC $1.33
- Resistance Level
- NYXH $6.09
- SXTC $1.97
- Average True Range (ATR)
- NYXH 0.26
- SXTC 0.21
- MACD
- NYXH -0.08
- SXTC 0.05
- Stochastic Oscillator
- NYXH 12.22
- SXTC 81.91
About NYXH Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.